Consolidated standards of reporting trials (CONSORT) for traditional Chinese medicine: current situation and future development
1. School of Chinese Medicine, Hong Kong Baptist University, Hong Kong, China; 2. China Academy of Chinese Medical Sciences, Beijing 100700, China; 3. Chalmers Research Group, Children’s Hospital of Eastern Ontario Research Institute, Ottawa, Canada; 4. Department of Clinical Epidemiology, Chinese Evidence-based Medicine Center, West China Hospital, Sichuan University, Chengdu 610041, China; 5. Tianjin University of Traditional Chinese Medicine, Tianjin 300193, China
发布日期：
2011-06-05
摘要
The reporting standards for randomized controlled trials were first published in 1996 by a group of scientists under the name “CONSORT,” which means consolidated standards of reporting trials. Revisions followed in 2001 and 2010. A draft of the CONSORT for traditional Chinese medicine (TCM) was published in both Chinese and English in 2007. After publication of the draft, comments were solicited from the medical community. Some papers did raise concerns about which items should be included in the CONSORT for TCM such as the rationale of the trial design, intervention, outcome assessment, and adverse events. We have now reached the next step which is the finalization of the CONSORT for TCM. Three tasks remain. First, the major changes in CONSORT statement 2010 should be integrated into the CONSORT for TCM. Second, Chinese drugs from minerals and animals should be included in the guidelines. Finally, agreement must be reached among the working groups. Once the draft is finalized, wide dissemination and co-publication will be considered.
京公网安备 11010502051620号
